These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 29361388)

  • 1. Quantitative analysis of elevation of serum creatinine via renal transporter inhibition by trimethoprim in healthy subjects using physiologically-based pharmacokinetic model.
    Nakada T; Kudo T; Kume T; Kusuhara H; Ito K
    Drug Metab Pharmacokinet; 2018 Feb; 33(1):103-110. PubMed ID: 29361388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of changes in serum creatinine and creatinine clearance caused by renal transporter inhibition in healthy subjects.
    Nakada T; Kudo T; Kume T; Kusuhara H; Ito K
    Drug Metab Pharmacokinet; 2019 Aug; 34(4):233-238. PubMed ID: 31176593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N(1)-methylnicotinamide as an endogenous probe for drug interactions by renal cation transporters: studies on the metformin-trimethoprim interaction.
    Müller F; Pontones CA; Renner B; Mieth M; Hoier E; Auge D; Maas R; Zolk O; Fromm MF
    Eur J Clin Pharmacol; 2015 Jan; 71(1):85-94. PubMed ID: 25552403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of non-linear Mate1-mediated efflux of trimethoprim in the mouse kidney as the mechanism underlying drug-drug interactions between trimethoprim and organic cations in the kidney.
    Kito T; Ito S; Mizuno T; Maeda K; Kusuhara H
    Drug Metab Pharmacokinet; 2019 Feb; 34(1):87-94. PubMed ID: 30528339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiologically-Based Pharmacokinetic Modelling of Creatinine-Drug Interactions in the Chronic Kidney Disease Population.
    Takita H; Scotcher D; Chinnadurai R; Kalra PA; Galetin A
    CPT Pharmacometrics Syst Pharmacol; 2020 Dec; 9(12):695-706. PubMed ID: 33049120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative Consideration of Clinical Increases in Serum Creatinine Caused by Renal Transporter Inhibition.
    Nakada T; Kudo T; Ito K
    Drug Metab Dispos; 2023 Sep; 51(9):1114-1126. PubMed ID: 36859345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tucatinib Inhibits Renal Transporters OCT2 and MATE Without Impacting Renal Function in Healthy Subjects.
    Topletz-Erickson AR; Lee AJ; Mayor JG; Rustia EL; Abdulrasool LI; Wise AL; Dailey B; DeChenne S; Walker LN; Alley SC; Endres CJ
    J Clin Pharmacol; 2021 Apr; 61(4):461-471. PubMed ID: 32989831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Physiologically-Based Pharmacokinetic Model of Trimethoprim for MATE1, OCT1, OCT2, and CYP2C8 Drug-Drug-Gene Interaction Predictions.
    Türk D; Hanke N; Lehr T
    Pharmaceutics; 2020 Nov; 12(11):. PubMed ID: 33182761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Complexities of Interpreting Reversible Elevated Serum Creatinine Levels in Drug Development: Does a Correlation with Inhibition of Renal Transporters Exist?
    Chu X; Bleasby K; Chan GH; Nunes I; Evers R
    Drug Metab Dispos; 2016 Sep; 44(9):1498-509. PubMed ID: 26825641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Renal Transporter Inhibition Using Creatinine as a Substrate In Vitro to Assess the Clinical Risk of Elevated Serum Creatinine.
    Mathialagan S; Rodrigues AD; Feng B
    J Pharm Sci; 2017 Sep; 106(9):2535-2541. PubMed ID: 28416419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal Transporter-Mediated Drug-Biomarker Interactions of the Endogenous Substrates Creatinine and N
    Türk D; Müller F; Fromm MF; Selzer D; Dallmann R; Lehr T
    Clin Pharmacol Ther; 2022 Sep; 112(3):687-698. PubMed ID: 35527512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact on creatinine renal clearance by the interplay of multiple renal transporters: a case study with INCB039110.
    Zhang Y; Warren MS; Zhang X; Diamond S; Williams B; Punwani N; Huang J; Huang Y; Yeleswaram S
    Drug Metab Dispos; 2015 Apr; 43(4):485-9. PubMed ID: 25605813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of trimethoprim on serum creatinine in healthy and chronic renal failure volunteers.
    Myre SA; McCann J; First MR; Cluxton RJ
    Ther Drug Monit; 1987 Jun; 9(2):161-5. PubMed ID: 3617154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimethoprim-metformin interaction and its genetic modulation by OCT2 and MATE1 transporters.
    Grün B; Kiessling MK; Burhenne J; Riedel KD; Weiss J; Rauch G; Haefeli WE; Czock D
    Br J Clin Pharmacol; 2013 Nov; 76(5):787-96. PubMed ID: 23305245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of tyrosine kinase inhibitors on renal handling of creatinine by MATE1.
    Omote S; Matsuoka N; Arakawa H; Nakanishi T; Tamai I
    Sci Rep; 2018 Jun; 8(1):9237. PubMed ID: 29915248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Whole-Body Physiologically Based Pharmacokinetic Model Characterizing Interplay of OCTs and MATEs in Intestine, Liver and Kidney to Predict Drug-Drug Interactions of Metformin with Perpetrators.
    Yang Y; Zhang Z; Li P; Kong W; Liu X; Liu L
    Pharmaceutics; 2021 May; 13(5):. PubMed ID: 34064886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of fluoroquinolone-induced elevation in serum creatinine levels: a case of drug-endogenous substance interaction involving the inhibition of renal secretion.
    Imamura Y; Murayama N; Okudaira N; Kurihara A; Okazaki O; Izumi T; Inoue K; Yuasa H; Kusuhara H; Sugiyama Y
    Clin Pharmacol Ther; 2011 Jan; 89(1):81-8. PubMed ID: 21124314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of trimethoprim-sulfamethoxazole on the renal excretion of creatinine in man.
    Berglund F; Killander J; Pompeius R
    J Urol; 1975 Dec; 114(6):802-8. PubMed ID: 1195454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steady state pharmacokinetics of trimethoprim 300 mg once daily in healthy volunteers assessed by two independent methods.
    Odlind B; Hartvig P; Fjellström KE; Lindström B; Bengtsson S
    Eur J Clin Pharmacol; 1984; 26(3):393-7. PubMed ID: 6734701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does elevation of serum creatinine in patients with chronic hepatitis C under therapy of telaprevir mean renal impairment?
    Matsui K; Kamijo-Ikemori A; Sugaya T; Ikeda H; Okuse C; Shibagaki Y; Yasuda T; Kimura K
    Nephrology (Carlton); 2015 Nov; 20(11):843-8. PubMed ID: 25998031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.